GlassScriptPhysician profile
Cynthia Shen
NPI 1962541821
$627.58
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $43.07 · 2021: $238 · 2022: $54.36.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $167.51 | 2021 | |
| Glaxosmithkline, LLC. | $99.55 | 2019-2022 | |
| Sanofi Pasteur INC. | $74.42 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.48 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $52.04 | 2019 | |
| Kaleo, INC. | $40.94 | 2019 | |
| Merck Sharp & Dohme LLC | $31.46 | 2019-2022 | |
| Tris Pharma INC | $21.01 | 2019 | |
| Shire North American Group INC | $20.83 | 2019 | |
| Adlon Therapeutics L.P. | $16.78 | 2019 | |
| Cranial Technologies, INC | $15.48 | 2019 | |
| Phadia US INC. | $14.15 | 2019 | |
| Pfizer INC. | $13.93 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Shen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.